Jiangsu Recbio Technology Co., Ltd. (Recbio) secured near-unanimous shareholder support for all eight ordinary resolutions tabled at its Annual General Meeting (AGM) held on 28 May 2026 in Taizhou, Jiangsu Province.
A total of 319.64 million shares—representing 51.05% of the company’s 626.08 million issued shares—were voted at the meeting. Each resolution received at least 99.99% of the votes cast in favour, with opposition limited to 4,500 votes (0.0014%) per item and negligible abstentions.
Key approvals included: • 2025 Financial Accounts Report. • 2026 Financial Budget Report. • 2025 Board Work Report and 2025 Annual Report. • Appointment of auditors for 2026. • 2026 remuneration scheme for directors. • 2025 profit distribution plan. • Proposed change in the use of proceeds.
All directors were in attendance. Voting was conducted by poll, with Computershare Hong Kong Investor Services Limited and two shareholder representatives acting as scrutineers. The meeting complied with the Company Law of the PRC, Hong Kong Listing Rules and Recbio’s Articles of Association.
Comments